Abstract

Purpose of review: The recent development of advanced systemic treatment options for pediatric atopic dermatitis (AD) means that achieving long-term, off-therapy remission, so-called disease modification, has become a subject of discussion. Emerging evidence suggests that early intervention during a potential 'window of opportunity' could alter the natural course of AD. If such a window could be identified, early and targeted treatment might induce long-term disease...